- Industrial or academic collaborations: What is a contract for ?
- What needs to be known and what are the differences between the contracts ?
The contractual arrangements with an industrial partner vary depending on the project. Inserm Transfert considers three main situations:
- a standard approach designed to make use of a patent, know-how, or proprietary biological material through the setting up of the licence agreement;
- a classical, simple collaborative R&D approach by setting up a collaborative agreement between an academic team and a company for a given project; where applicable, combined with a licence agreement;
- an approach involving establishment of customised long term partnerships with companies (generally middle size companies or large groups), based on specific identification of the company’s needs and linked to the specific expertise of the teams and/or high potential value patents on the subjects in question.
These contracts govern the relationship which you and your team will have with the industrial partner, fixing the type of agreement, collaboration methods and access to intellectual property (patents, know-how, biological materials), the scientific programme, ownership of the results which are obtained from it and the funding conditions. The written contract formalises a discussion which determines the funding of the research programme and sets the financial returns from use of the patents, know-how and biological materials involved.
Other contracts govern:
- exchange of information for assessment: this occurs once a confidentiality agreement,
- or CDA (confidential disclosure agreement), is in place; exchange of material: this is a material transfer agreement (or MTA).